2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z

Baclofen-Induced Worsening of Parkinsonism in a Patient with CADASIL and Brainstem Stroke

Y-H. Wu (Taipei, Taiwan)
Baicalein Attenuates Rotenone-Induced Neurodegeneration by Regulating BDNF/CREB/Akt Signaling in Parkinson’s Disease

A. Singh (Solan, India)
Barriers and Enablers to Diversity and Inclusion in Movement Disorders Research (BIND-MD)

H. Collins, E. Manoharan, S. Gandhi, A. Zarkali, A. Batla (London, United Kingdom)
Barriers to Disease-Modifying Clinical Trials in Parkinson’s Disease: A Survey of Clinicians and Researchers Involved in Clinical Trials

J A. de Marcaida, K. Kearney, S. Mccarthy, G. Woolery, K. Hespeler, M. Hespeler, S. Dewitte, A. Espay (Vernon, USA)
Basal ganglia and cerebellum involvement in Myelin Oligodendrocyte antibody associated disease (MOGAD) presenting with facial Dystonia and limb Tremer

N. Sinha, A. Ranjan, R. Singh (Patna, India)
Basal Ganglia Germinoma (BGG) Presenting as Hemidystonia

C. Ryan, R. Patel, S. Younes, M. Chintagumpala, N. Gadgil, M. Parnes (Houston, USA)
Basal Ganglia Hypointensity Associated with Glucose Transporter Type 1 Deficiency Syndrome (GLUT1-DS)

C. Jiménez Clopés, Y. Estrella Domínguez, J. Balsa Vázquez, A. Rojo Sebastián (Alcalá de Henares, Madrid, Spain)
Basal Ganglia Lacunar Infarcts and Risk of Mortality and Dementia in Parkinsonism: A Population-Based Study

L. Malfer, F. Onorati, A. Mullan, R. Savica (Rochester, USA)
Basal Ganglia Pathway Recruitment Determines Bidirectional Bradykinesia Modulation by DBS in Humans

P. Navratil, A. Schmidt, H. Eldebakey, N. Rajamani, V. Odekerken, R. de Bie, C. Zhang, K. Kimura, G. Abbas, R. Peach, J. Roothans, J. Volkmann, F. Lange, M. Reich (Wuerzburg, Germany)
Baseline assessment of nigrostriatal integrity via VMAT2 PET in participants with Parkinson’s disease from the BIIB122/DNL151 LUMA Phase 2b study

A. Hone-Blanchet, R. Llorens-Arenas, B. Hersh, O. Mabrouk, J. Dubois, D. Jennings, M. Clarke, A. Wittington, M. Wald, D. Graham, M. Hutchison (Cambridge, USA)
Baseline auditory-perceptual speech ratings predict improvement in voice intensity after group-based speech intervention in Parkinson’s disease

H. Steurer, E. Schalling, E. Franzén, J. Gustafsson, F. Albrecht (Stockholm, Sweden)
Baseline characteristics of fallers versus non-fallers in a remote, decentralized study of Parkinson’s disease

P. Auinger, R. Wilson, C. Roe, A. Ascherio, J. Beck, S. Benvengo, K. Biglan, E. Dorsey, A. Espay, E. Macklin, M. Monje, E. Neto, D. Novak, M. Schwarzschild, S. Sieberts, T. Simuni, C. Tanner, D. Weintraub, R. Schneider (Rochester, USA)
Baseline Characteristics of Participants Enrolled in a Randomised Pilot Study of Enhanced Tai Chi for Parkinson’s disease

M. Qamar, O. Awogbemila, R. Savla, L. Batzu, S. Rota, A. Hernandez Pena, C. Yang, M. Freris, B. Dikong, J. Whitney (London, United Kingdom)
Baseline Factors Associated with Sublingual Apomorphine Film Maintenance Dose

J. Kassubek, J. Schwarz, L. López Manzanares, J. Reis, H. C. Brigas, C. Denecke-Muhr, J. Holenz (Ulm, Germany)
Baseline MRI Predictors of Phenoconversion and Prodromal Progression in Non-Manifesting PD Mutation Carriers: A Longitudinal Retrospective Analysis

AD. Droby, BK. Krayem, SA. Abed, NN. Nguyen, DE. Eidelberg, AV. Vo, AM. Mirelmen, AT. Thaler (Tel Aviv, Israel)
Baseline plasma neurofilament light and phosphorylated tau 181 levels predict longitudinal cognitive decline in APOE4 and long SNCA Rep1 carriers in Parkinson’s disease

S. Ng, J. Tan, E. Saffari, E. Ng, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Tan, A. Ng (Singapore, Singapore)
Bayesian Network Analysis of Directional Relationships Among Motor and Non-Motor Symptoms in Parkinson’s Disease

A. Al-Sharman, H. Khalil, D. Malouche, S. Kanaan, M. Kim, N. Saad, M. Abdelrazeq (Sharjah, United Arab Emirates)
Behavioral Phenotype of a Mouse Model of Mixed Movement Disorders Linked to ADCY5

J. Baik, E. Conabady, M. Doulazmi, R. Yuan, C. Dubacq, E. Roze (Paris, France)
Benefit of Telemedicine Usage in Parkinson’s Disease Patients in Appalachia

S. Rashid, D. Fletcher, J. Frey (Morgantown, USA)
Beta and Gamma Local Field Potentials in Chronic Deep Brain Stimulation for Parkinson’s Disease: Programming Implications from a Systematic Review

KS. Thu Aung, S. Lane, J. Osman-Farah, A. Macerollo (Liverpool, United Kingdom)
Beta–motor state correspondence as a predictor of adaptive deep brain stimulation benefit in Parkinson’s disease

T. Hashimoto, J. Tanimura, T. Yako (Matsumoto, Japan)
Beyond Diagnosis: Putaminal ADC Hyperintensity and Infratentorial Signs Reflect Motor Severity in MSA

Y. Zhao, K. Li, Y. Zheng, M. Luan, H. Tang, C. He, J. Liu, F. Li, L. Wei, J. Chen, W. Sun, J. Deng, Z. Wang, Y. Zhu, Y. Sun (Beijing, China)
Beyond Freezing of Gait Episodes in Parkinson’s Disease: Intercritical Kinematic Gait Pattern Matters.

G. de Biasi, F. Di Filippo, L. Santos, C. Ricciardi, M. Russo, N. Pisani, MC. Calabrese, M. Romano, M. Picillo, R. Erro, MT. Pellecchia, P. Barone, M. Amboni (Salerno, Italy)
Beyond Motor Fluctuations: Non-Motor and Quality-Of-Life Outcomes with Subcutaneous Foslevodopa/Foscarbidopa Infusion in Real-World Practice

V. Pérez-Del-Olmo, B. De-La-Casa-Fages, JR. Pérez-Sánchez, A. Bonilla-Tena, A. Contreras-Chicote, E. Luque-Buzo, E. González-Turiño, FJ. Grandas-Pérez (Madrid, Spain)
Beyond Motor Outcomes: Health Literacy, Medication Adherence, and Quality of Life in Parkinson’s Disease Patients Undergoing the Levodopa Challenge Test

M. da Silva, M. Tosin, L. Silveira-Moriyama (Campinas, Brazil)
Beyond Motor Symptoms: Utilizing the FreeSurfer Brainstem Substructures Module to Characterize a Complex Parkinsonian Phenotype with Profound Dysautonomia

M L. Chin, A K. Lee (Ipoh, Malaysia)
Beyond Movement Amplitude: Interaction‑ and Asymmetry‑Aware Facial Blendshape Analysis in Parkinsonian Hypomimia

B. Koyak, T. Menzel, A. Spottke, J. Faber, M. Reuter, U. Wüllner, M. Botsch, A. Aziz (Bonn, Germany)
Beyond Parkinson’s Disease, Impulse Control Dysregulation: The Psychosocial Correlates of Problematic Internet Use

T. Adeoye, O. Buhari, O. Adeoye (Ogbomoso, Nigeria)
Beyond Relaxation: Can Self-Initiated Therapeutic Tremors Improve Functional Gait and ADL in Parkinson’s Disease?

E. Atterbury, K. Welman (Stellenbosch, South Africa)
Beyond Symptom Relief: Physician Empathy Outperforms Clinical Severity in Predicting Quality of Life for Patients Undergoing Botulinum Toxin Therapy

T. Kölsche, R. Jansen, M. Ringelstein, S. Meuth, J. Lee, P. Albrecht (Düsseldorf, Germany)
Beyond the “best contact”: correlation of ai-guided dbs contact distribution and subthalamic nucleus beta physiology in parkinson’s disease patients

S. Obika, M. Del Alamo, D. Ortiz-Zacarías, C. Fernandez, F. Alonso-Frech (Madrid, Spain)
Beyond the Brain: Resting Tremor as a Presentation of Cervical Spinal Schwannoma

T. Abu-Zahra, I. Goldszer (Detroit, USA)
Beyond the Spinal Tap: Diagnostic Accuracy of Alpha-Synuclein Seeding Amplification Assays (SAA) in Cutaneous and Ocular Biofluids – A Comparative Diagnostic Accuracy Review

F. Al-Zaidi (Almaty, Kazakhstan)
Beyond α-Synuclein SAA: A Multimodal Minimally Invasive Platform for Biologically Informed Diagnosis of Parkinsonian Syndromes

I. Martinez-Valbuena, M. Abarghouei, D. Olszewska, S. Weber, S. Schnell, M. Sousa, D. Di Luca, N. Reyes, SM. Fereshtehnejad, J. Ta, C. Anastassiadis, J. Li, J. Sasitharan, N. Visanji, S. Fox, B. Mollenhauer, C. Tartaglia, G. Kovacs, A. Lang (Toronto, Canada)
Bidirectional Association Between Gout and Parkinson’s Disease: A Systematic Review and Meta-Analysis

V. Byroju, J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)
Bidirectional associations between seizures and parkinsonism: a retrospective case series

Y. Chen, J. Fleisher, R. O'Dwyer (Chicago, USA)
Bilateral Globus Pallidus Internus Deep Brain Stimulation for Myoclonus-Dystonia in Variant Ataxia-Telangiectasia: A Case Report

S. Liang, Y. Shao, Y. Yu, J. Wu, F. Wu, T. Zhang, X. Hu, Q. Wang (Tianjin, China)
Bilateral GPi Deep Brain Stimulation for Severe Speech-Induced Dystonic Dysfluency: A Novel Phenotype at the Stuttering-Dystonia Interface

Y. Abdelmajid, S. Mittal, T. Maiti (Abu Dhabi, United Arab Emirates)
Bilateral Hemifacial Spasm Caused by In-Ear Hearing Aids

J. Thomas, N. Schuck, K. Mangipudi (Jacksonville, USA)
Bilateral MRgFUS thalamotomy in essential tremor: a prospective case series using probabilistic tractography

A. Fernández Revuelta, C. Ribacoba Díaz, A. Aldaz, E. López-Valdés, C. Perez Garcia, M. Yus, A. Trondin, A. López-Frías, C. Trejo Gallego, R. Garcia-Ramos (Madrid, Spain)
Binge-eating as an Initial Presentation for the Diagnosis of Chorea-acanthocytosis

K M. Lau, Y H. Lau (London, United Kingdom)
Biochemical and Nutritional Changes During Continuous Subcutaneous Apomorphine Infusion in Advanced Parkinson’s Disease: Findings from an Observational Cohort

O. Phokaewvarangkul, N. Rattanapitak, P. Kuwattanasuchati, R. Bhidayasiri (Bangkok, Thailand)
Biofluid Markers in Parkinson’s Patients and Correlation with Cognitive Profile

T. Yamasaki, R. Vivanco, J. Johnson, S. Ali, F. Schmitt, A. Glueck, A. Jacob, S. Hulou, M. Khashimov, K. Tackett, C. Logan, J. Stegemann, E. Song, E. Ostrakhovitch (Lexington, USA)
Biological Predictors of Clinical Domains in Isolated REM Sleep Behavior Disorder with and without Synucleinopathy and Dopamine Dysfunction

D. Weintraub (Philadelphia, USA)
Biomarker and Clinical Correlates of Restless Legs Syndrome (RLS) in Parkinson’s Disease: A Paradoxical Hyperdopaminergic State

SM. Fereshtehnejad, J. Valerio, N. Ayas (Vancouver, Canada)
Biomarker-Informed Survival Modelling Using Plasma Neurofilament Light and Clinical Predictors in a Prospective Multiple System Atrophy Cohort

V. Chelban, L. Lei, C. Lee, Y. Goh, I. Karagoz, R. Lee, H. Morris, N. Vijiaratnam, T. Foltynie, H. Houlden (London, United Kingdom)
Biomechanical Analysis of Gait Movement Disorders in Spinal Cord Injury and Its Implications for Rehabilitation Strategies

M. Gupta, B. Garg (New Delhi, India)
Bisphenol S: A Potential Environmental Modifier of LRRK2-Associated Parkinson’s disease

B. Talavera Andújar, J. Ghelfi, I. Goglia, M. Tziortziou, M. Borsche, C. Klein, E. Schymanski, A. Grünewald (Belvaux, Luxembourg)
Blood glucose homeostasis is conserved in patients with mild to moderate Spinocerebellar Ataxia type 2

R. Aguilera-Rodríguez, D. Almaguer-Gotay, A. álvarez-Sosa, M. Anidos-Machado, Y. Silva-Ricardo, D. Cuello-Almarales, A. Estupiñán-Rodríguez, L. Almaguer-Mederos (Holguín, Cuba)
Body Weight Increases After DBS in Parkinson’s Disease but Not Essential Tremor

C. Tinch, S. Brinkerhoff, H. Walker, S. Frank, C. Ferguson (Birmingham, USA)
Boosting cerebellum/M1 and PPC/M1 communication via tACS to improve cued gait in Parkinson’s disease patients unresponsive to auditory cueing strategies.

E. Pelosin, A. Botta, V. Romano, J. Nonnekes, M. Gilat, I. Maidan, A. Mirelman, L. Avanzino (Genova, Italy)
Botulinum toxin treatment patterns and outcomes in head and neck dystonia: experience from a tertiary, multidisciplinary clinical service

R. Everitt, R. Aggarwal, R. Mcdonagh, C. Kobylecki (Salford, United Kingdom)
Boxing-Based Exercise Programs for Parkinson’s Disease: A Review of Motor and Quality-of-Life Outcomes

C. Hu, T. Tran (San Antonio, USA)
Brain Atlas-Based Machine Learning for Parkinsonian Disorders Classification and Evaluation of Classification Performance Across Disease Duration

S. Kim, S. Oh, H. Yoo, W. Kim, J. Youn, JW. Cho (Seoul, Republic of Korea)
Brain-Derived Neurotrophic Factor as a Biomarker of Depression in Parkinson’s Disease

IH. Kwak, YE. Kim, HI. Ma, JK. Yu, DG. Ko, JJ. Lee, HD. Nguyen, HBT. Tran, HJ. Choi, SJ. Song (Anyang, Republic of Korea)
Brain-First and Body-First Model Translated to Individual-Level Characterization in Parkinson’s Disease: Multimodal Imaging and Clinical Approach

K. Colman, I. de Volder, S. Ceyssens, J. Verbraecken, M. Viaene, O. Wolfgang, A. Janzen, A. Pijpers, D. Crosiers, F. Dijkstra (Edegem, Belgium)
Brain-targeted dual-loaded extracellular vesicles enable PROTAC-mediated LRRK2 degradation in Parkinson’s disease

JEK. Kim, YH. Yang, OYB. Bang (Seoul, Republic of Korea)
Bridging Genetics and Precision Medicine in Parkinson’s Disease through GP2: Translating Genetic Risk into Trial-Eligible GBA1 and LRRK2 Cohorts

L. Lange, K. Atterling Brolin, E. Navarro-Jones, M. Tan, S. Meyer, D. Vitale, A. Singleton, C. Blauwendraat, M. Nalls, A. Noyce, H. Morris (Bethesda, USA)
Bridging the Gap: Physical Activity and Rehabilitation Patterns in Patients with Parkinsonism

J. Pona-Ferreira, M. Perdicoúlis, N. Ribeiro, M. Vargas, R. Raimundo, AG. Velon (Vila Real, Portugal)
Bridging the Genomic Gap: Ancestry-Aware Polygenic Risk and Variant Discovery in African Parkinson’s Disease Cohorts

B. Adebisi (Osogbo, Nigeria)
Built Environment and Accessibility to Parkinson’s Disease Community Programs: A Preliminary Analysis

C. Onuigbo, S. Garcia, C. Tran, J. Martinez-Lemus, S. Chandra, M. Schiess (Houston, USA)
Burden and Geographic Distribution of Parkinson’s Disease in Mexico: A GBD 2021 Analysis (1990-2023)

K. Farias-Moreno, KC. Carrazco-Peña, E. Gómez-Figueroa, CZ. Zúñiga-Ramírez (Guadalajara, Mexico)
Burst versus Conventional Deep Brain Stimulation Engage Distinct Cortico-Subthalamic Circuit Dynamics in Parkinson’s Disease

T. Sil, L. Lange, L. Juarez-Paz, B. Duarte, H. Bokil, M. Reich, M. Muthuraman, J. Volkmann (Wuerzburg, Germany)

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z